118.79
0.33%
-0.3712
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RVTY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$119.16
Offen:
$119.04
24-Stunden-Volumen:
579.87K
Relative Volume:
0.65
Marktkapitalisierung:
$14.40B
Einnahmen:
$2.72B
Nettoeinkommen (Verlust:
$254.30M
KGV:
57.48
EPS:
2.0665
Netto-Cashflow:
$564.37M
1W Leistung:
-5.83%
1M Leistung:
+1.86%
6M Leistung:
+2.71%
1J Leistung:
+15.43%
Revvity Inc Stock (RVTY) Company Profile
Firmenname
Revvity Inc
Sektor
Branche
Telefon
781-663-6900
Adresse
77 4TH AVENUE, WALTHAM
Vergleichen Sie RVTY mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
118.78 | 14.40B | 2.72B | 254.30M | 564.37M | 2.0665 |
TMO
Thermo Fisher Scientific Inc
|
571.77 | 218.67B | 42.88B | 6.34B | 7.27B | 16.53 |
DHR
Danaher Corp
|
205.87 | 148.44B | 23.88B | 3.90B | 5.30B | 5.28 |
A
Agilent Technologies Inc
|
145.78 | 41.57B | 6.51B | 1.29B | 1.37B | 4.42 |
IDXX
Idexx Laboratories Inc
|
458.77 | 37.56B | 3.84B | 866.24M | 792.60M | 10.37 |
IQV
Iqvia Holdings Inc
|
207.93 | 36.56B | 15.32B | 1.41B | 1.96B | 7.62 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-10 | Herabstufung | Bernstein | Outperform → Mkt Perform |
2024-12-13 | Hochstufung | BofA Securities | Neutral → Buy |
2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
2024-07-08 | Eingeleitet | Leerink Partners | Outperform |
2024-06-03 | Fortgesetzt | Jefferies | Hold |
2024-01-16 | Herabstufung | UBS | Buy → Neutral |
2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
2023-09-28 | Eingeleitet | Bernstein | Outperform |
2023-07-19 | Eingeleitet | Raymond James | Outperform |
2023-05-23 | Fortgesetzt | Goldman | Buy |
Alle ansehen
Revvity Inc Aktie (RVTY) Neueste Nachrichten
KeyCorp Forecasts Strong Price Appreciation for Revvity (NYSE:RVTY) Stock - MarketBeat
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Trust Point Inc. Purchases Shares of 4,594 Revvity, Inc. (NYSE:RVTY) - MarketBeat
Barclays Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (NYSE:RVTY) Updates FY 2025 Earnings Guidance - MarketBeat
Jefferies raises Revvity stock price target to $130, maintains Hold - MSN
Revvity anticipates 3%-5% organic growth in 2025 amid market stabilization - MSN
Revvity, Inc. (NYSE:RVTY) Insider Joel S. Goldberg Sells 15,170 Shares - MarketBeat
Revvity’s Strong Recurring Revenue and Growth Prospects Justify Buy Rating - TipRanks
Exchange Traded Concepts LLC Sells 3,502 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Raymond James Adjusts Price Target on Revvity to $145 From $140 -February 03, 2025 at 11:43 am EST - Marketscreener.com
KeyBanc Adjusts Revvity Price Target to $145 From $132 -February 03, 2025 at 11:26 am EST - Marketscreener.com
Revvity (NYSE:RVTY) Receives "Outperform" Rating from Raymond James - MarketBeat
Revvity (RVTY) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2024 Earnings Call Transcript - MSN
Revvity shares leap over 5% as Q4 earnings top estimates - MSN
Revvity (RVTY) Surpasses Q4 Earnings Estimates - MSN
Revvity’s Strong Q4 Performance and 2025 Outlook - TipRanks
Revvity (NYSE:RVTY) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Earnings call transcript: Revvity Q4 2024 shows steady growth amid mixed market reaction - MSN
Jefferies raises Revvity stock price target to $130, maintains Hold By Investing.com - Investing.com Australia
Revvity Inc (RVTY) Q4 2024 Earnings Call Highlights: Strong Organic Growth and Strategic ... - Yahoo Finance
Revvity Reports Positive 2024 Financial Results - TipRanks
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations By Stock Story - Investing.com Canada
Revvity (NYSE:RVTY) Reports Q4 In Line With Expectations - Yahoo Finance
RVTY Q4 Earnings Beat Estimates, Sales Miss, Segments Robust - MSN
Revvity's 2025 Guidance Signals Cautious Optimism Amid Slower-Than-Expected Pharma Spending Recovery - Morningstar
Citigroup Raises Price Target on Revvity to $155 From $145 -January 31, 2025 at 02:24 pm EST - Marketscreener.com
Evercore ISI Adjusts Price Target on Revvity to $138 From $125 -January 31, 2025 at 11:35 am EST - Marketscreener.com
Revvity Predicts Lower 2025 Earnings Despite Strong Fourth Quarter - Finimize
Revvity: Q4 Earnings Snapshot - Houston Chronicle
Revvity forecasts 2025 revenue, profit below estimates amid weak biotech spending - MSN
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024 - BioSpace
Revvity Inc (RVTY) Q4 2024 Earnings: EPS of $0.78 Beats Estimates, Revenue Hits $729 Million - GuruFocus.com
Finanzdaten der Revvity Inc-Aktie (RVTY)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):